Summit Therapeutics (SMMT) had the highest return in Q3 2024 by a large-cap US stock, returning 179.3%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | Q3 2024 | 179.34% |
Ast Spacemobile (ASTS) | Q3 2024 | 120.68% |
Rocket Lab USA (RKLB) | Q3 2024 | 103.56% |
Regencell Bioscience (RGC) | Q3 2024 | 77.06% |
Xpeng (XPEV) | Q3 2024 | 63.27% |
EXACT Sciences (EXAS) | Q3 2024 | 61.38% |
BeiGene (ONC) | Q3 2024 | 55.59% |
JD Inc Adr (JD) | Q3 2024 | 54.26% |
Nio Inc Class A ADR (NIO) | Q3 2024 | 53.56% |
Applovin (APP) | Q3 2024 | 53.37% |
Ubiquiti Networks (UI) | Q3 2024 | 52.33% |
Bilibili (BILI) | Q3 2024 | 49.68% |
GE Vernova LLC (GEV) | Q3 2024 | 49.11% |
Erie Indemnity (ERIE) | Q3 2024 | 48.73% |
BioNTech SE (BNTX) | Q3 2024 | 48.06% |
Alibaba (BABA) | Q3 2024 | 46.35% |
Palantir Technologies (PLTR) | Q3 2024 | 46% |
Carpenter Technology (CRS) | Q3 2024 | 45.74% |
Futu (FUTU) | Q3 2024 | 44.97% |
Yum China (YUMC) | Q3 2024 | 44.52% |
SharkNinja (SN) | Q3 2024 | 44.31% |
Samsara (IOT) | Q3 2024 | 43.21% |
IES (IESC) | Q3 2024 | 42.02% |
TransUnion (TRU) | Q3 2024 | 41.13% |
CBRE Group Inc Class A (CBRE) | Q3 2024 | 40.23% |
Large-cap stocks are treated as having a market cap of $10B+.
